𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early selegiline therapy reduces levodopa dose requirement in Parkinson's disease

✍ Scribed by V. V. Myllylä; E. H. Heinonen; J. A. Vuorinen; O.I. Kilkku; K. A. Sotaniemi


Book ID
114784363
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
493 KB
Volume
91
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Levodopa response in early Parkinson's d
✍ Robert A. Hauser; Peggy Auinger; David Oakes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks

Early combination therapy with bromocrip
✍ Dr. Stewart A. Factor; William J. Weiner 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

## Abstract The use of early combination therapy with bromocriptine (Br) and levodopa (LD) in Parkinson's disease is controversial. It has been suggested that treatment with this regimen would prevent or delay the onset of motor fluctuations and dyskinesia. Thus, some have recommended it as a stand